5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;6-[1-[3-[4-(2-fluoroethyl)piperazin-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridine;3-methyl-5-[5-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-1-propan-2-ylpyrazol-3-yl]pyridin-2-amine;4-[3-[3-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylpyrazol-5-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-3-(1-pyridin-2-ylethoxy)pyridin-2-amine)

C150H192F4N34O6 — CID 158232348

IUPAC5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;6-[1-[3-[4-(2-fluoroethyl)piperazin-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridine;3-methyl-5-[5-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-1-propan-2-ylpyrazol-3-yl]pyridin-2-amine;4-[3-[3-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylpyrazol-5-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-3-(1-pyridin-2-ylethoxy)pyridin-2-amine)
SMILESCC(C)c1nc(-c2cnc(N)c(OC(C)c3ccccn3)c2)cn1C12CC(N3CCOCC3)(C1)C2.CC(C)c1nc(-c2cnc(N)c(OC(C)c3ccccn3)c2)cn1C12CC(N3CCOCC3)(C1)C2.CC(C)c1nc(-c2cnc3ccn(C(C)c4ccccn4)c3c2)cn1C12CC(N3CCN(CCF)CC3)(C1)C2.Cc1cc(-c2cc(C34CC(N5CCOCC5)(C3)C4)n(C(C)C)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCN(C)CC5)(C3)C4)c(C3CC3)n2)cnc1N.Cc1ncc(-c2cc(C34CC(N5CCOCC5)(C3)C4)n(C(C)C)n2)cc1C(F)(F)F
InChIInChI=1S/C31H38FN7.2C27H34N6O2.C22H27F3N4O.C22H30N6.C21H29N5O/c1-22(2)29-35-27(18-39(29)31-19-30(20-31,21-31)37-14-12-36(11-8-32)13-15-37)24-16-28-26(34-17-24)7-10-38(28)23(3)25-6-4-5-9-33-25;2*1-18(2)25-31-22(14-33(25)27-15-26(16-27,17-27)32-8-10-34-11-9-32)20-12-23(24(28)30-13-20)35-19(3)21-6-4-5-7-29-21;1-14(2)29-19(20-11-21(12-20,13-20)28-4-6-30-7-5-28)9-18(27-29)16-8-17(22(23,24)25)15(3)26-10-16;1-15-9-17(10-24-19(15)23)18-11-28(20(25-18)16-3-4-16)22-12-21(13-22,14-22)27-7-5-26(2)6-8-27;1-14(2)26-18(9-17(24-26)16-8-15(3)19(22)23-10-16)20-11-21(12-20,13-20)25-4-6-27-7-5-25/h4-7,9-10,16-18,22-23H,8,11-15,19-21H2,1-3H3;2*4-7,12-14,18-19H,8-11,15-17H2,1-3H3,(H2,28,30);8-10,14H,4-7,11-13H2,1-3H3;9-11,16H,3-8,12-14H2,1-2H3,(H2,23,24);8-10,14H,4-7,11-13H2,1-3H3,(H2,22,23)
InChIKeyGENLGDFXFKVGLB-UHFFFAOYSA-N
MW2643.41 g/mol
LogP23.42
Rot. Bonds34

About 5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;6-[1-[3-[4-(2-fluoroethyl)piperazin-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridine;3-methyl-5-[5-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-1-propan-2-ylpyrazol-3-yl]pyridin-2-amine;4-[3-[3-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylpyrazol-5-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-3-(1-pyridin-2-ylethoxy)pyridin-2-amine)

5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;6-[1-[3-[4-(2-fluoroethyl)piperazin-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridine;3-methyl-5-[5-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-1-propan-2-ylpyrazol-3-yl]pyridin-2-amine;4-[3-[3-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylpyrazol-5-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-3-(1-pyridin-2-ylethoxy)pyridin-2-amine) (PubChem CID 158232348) has the molecular formula C150H192F4N34O6 and a molecular weight of 2643.41 g/mol. Its IUPAC name is 5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;6-[1-[3-[4-(2-fluoroethyl)piperazin-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridine;3-methyl-5-[5-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-1-propan-2-ylpyrazol-3-yl]pyridin-2-amine;4-[3-[3-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylpyrazol-5-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-3-(1-pyridin-2-ylethoxy)pyridin-2-amine).

Molecular Properties

Compound Name5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;6-[1-[3-[4-(2-fluoroethyl)piperazin-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridine;3-methyl-5-[5-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-1-propan-2-ylpyrazol-3-yl]pyridin-2-amine;4-[3-[3-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylpyrazol-5-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-3-(1-pyridin-2-ylethoxy)pyridin-2-amine)
PubChem CID158232348
Molecular FormulaC150H192F4N34O6
Molecular Weight2643.41 g/mol
Exact Mass2641.57
IUPAC Name5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;6-[1-[3-[4-(2-fluoroethyl)piperazin-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridine;3-methyl-5-[5-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-1-propan-2-ylpyrazol-3-yl]pyridin-2-amine;4-[3-[3-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylpyrazol-5-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-3-(1-pyridin-2-ylethoxy)pyridin-2-amine)
SMILESCC(C)c1nc(-c2cnc(N)c(OC(C)c3ccccn3)c2)cn1C12CC(N3CCOCC3)(C1)C2.CC(C)c1nc(-c2cnc(N)c(OC(C)c3ccccn3)c2)cn1C12CC(N3CCOCC3)(C1)C2.CC(C)c1nc(-c2cnc3ccn(C(C)c4ccccn4)c3c2)cn1C12CC(N3CCN(CCF)CC3)(C1)C2.Cc1cc(-c2cc(C34CC(N5CCOCC5)(C3)C4)n(C(C)C)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCN(C)CC5)(C3)C4)c(C3CC3)n2)cnc1N.Cc1ncc(-c2cc(C34CC(N5CCOCC5)(C3)C4)n(C(C)C)n2)cc1C(F)(F)F
InChIInChI=1S/C31H38FN7.2C27H34N6O2.C22H27F3N4O.C22H30N6.C21H29N5O/c1-22(2)29-35-27(18-39(29)31-19-30(20-31,21-31)37-14-12-36(11-8-32)13-15-37)24-16-28-26(34-17-24)7-10-38(28)23(3)25-6-4-5-9-33-25;2*1-18(2)25-31-22(14-33(25)27-15-26(16-27,17-27)32-8-10-34-11-9-32)20-12-23(24(28)30-13-20)35-19(3)21-6-4-5-7-29-21;1-14(2)29-19(20-11-21(12-20,13-20)28-4-6-30-7-5-28)9-18(27-29)16-8-17(22(23,24)25)15(3)26-10-16;1-15-9-17(10-24-19(15)23)18-11-28(20(25-18)16-3-4-16)22-12-21(13-22,14-22)27-7-5-26(2)6-8-27;1-14(2)26-18(9-17(24-26)16-8-15(3)19(22)23-10-16)20-11-21(12-20,13-20)25-4-6-27-7-5-25/h4-7,9-10,16-18,22-23H,8,11-15,19-21H2,1-3H3;2*4-7,12-14,18-19H,8-11,15-17H2,1-3H3,(H2,28,30);8-10,14H,4-7,11-13H2,1-3H3;9-11,16H,3-8,12-14H2,1-2H3,(H2,23,24);8-10,14H,4-7,11-13H2,1-3H3,(H2,22,23)
InChIKeyGENLGDFXFKVGLB-UHFFFAOYSA-N
XLogP23.42
TPSA413.24 Ų
H-Bond Donors4
H-Bond Acceptors40
Rotatable Bonds34
Heavy Atoms194
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002643.41
LogP ≤ 523.42
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1040

Analyze 5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;6-[1-[3-[4-(2-fluoroethyl)piperazin-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridine;3-methyl-5-[5-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-1-propan-2-ylpyrazol-3-yl]pyridin-2-amine;4-[3-[3-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylpyrazol-5-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-3-(1-pyridin-2-ylethoxy)pyridin-2-amine) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

WO2022090481, Example I-022
CID 163273430
(1R,4R)-5-[2-[(8aR)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]-6-[6-(4-methoxy-3-pyridinyl)-4-methylpyrazolo[4,3-c]pyridin-1-yl]-1-methylimidazo[4,5-c]pyridin-4-yl]-2-oxa-5-azabicyclo[2.2.1]heptane
CID 164514234
WO2022090481, Example I-173
CID 163273431
WO2022090481, Example I-180
CID 164514238
WO2022090481, Example I-221
CID 164514250
US10112942, Example 472
CID 134436634
WO2022090481, Example I-172
CID 163273356
WO2022090481, Example I-189
CID 163273365
WO2022090481, Example I-218
CID 163273387
WO2022090481, Example I-024
CID 163273392
WO2022090481, Example I-178
CID 163273394
WO2022090481, Example I-207
CID 163273471

Frequently Asked Questions

What is the IUPAC name of 5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;6-[1-[3-[4-(2-fluoroethyl)piperazin-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridine;3-methyl-5-[5-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-1-propan-2-ylpyrazol-3-yl]pyridin-2-amine;4-[3-[3-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylpyrazol-5-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-3-(1-pyridin-2-ylethoxy)pyridin-2-amine)?
The IUPAC name of 5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;6-[1-[3-[4-(2-fluoroethyl)piperazin-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridine;3-methyl-5-[5-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-1-propan-2-ylpyrazol-3-yl]pyridin-2-amine;4-[3-[3-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylpyrazol-5-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-3-(1-pyridin-2-ylethoxy)pyridin-2-amine) (CID 158232348) is 5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;6-[1-[3-[4-(2-fluoroethyl)piperazin-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridine;3-methyl-5-[5-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-1-propan-2-ylpyrazol-3-yl]pyridin-2-amine;4-[3-[3-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylpyrazol-5-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-3-(1-pyridin-2-ylethoxy)pyridin-2-amine).
What is the SMILES notation for 5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;6-[1-[3-[4-(2-fluoroethyl)piperazin-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridine;3-methyl-5-[5-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-1-propan-2-ylpyrazol-3-yl]pyridin-2-amine;4-[3-[3-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylpyrazol-5-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-3-(1-pyridin-2-ylethoxy)pyridin-2-amine)?
The canonical SMILES for 5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;6-[1-[3-[4-(2-fluoroethyl)piperazin-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridine;3-methyl-5-[5-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-1-propan-2-ylpyrazol-3-yl]pyridin-2-amine;4-[3-[3-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylpyrazol-5-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-3-(1-pyridin-2-ylethoxy)pyridin-2-amine) is CC(C)c1nc(-c2cnc(N)c(OC(C)c3ccccn3)c2)cn1C12CC(N3CCOCC3)(C1)C2.CC(C)c1nc(-c2cnc(N)c(OC(C)c3ccccn3)c2)cn1C12CC(N3CCOCC3)(C1)C2.CC(C)c1nc(-c2cnc3ccn(C(C)c4ccccn4)c3c2)cn1C12CC(N3CCN(CCF)CC3)(C1)C2.Cc1cc(-c2cc(C34CC(N5CCOCC5)(C3)C4)n(C(C)C)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCN(C)CC5)(C3)C4)c(C3CC3)n2)cnc1N.Cc1ncc(-c2cc(C34CC(N5CCOCC5)(C3)C4)n(C(C)C)n2)cc1C(F)(F)F.
What is the InChIKey of 5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;6-[1-[3-[4-(2-fluoroethyl)piperazin-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridine;3-methyl-5-[5-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-1-propan-2-ylpyrazol-3-yl]pyridin-2-amine;4-[3-[3-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylpyrazol-5-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-3-(1-pyridin-2-ylethoxy)pyridin-2-amine)?
The InChIKey is GENLGDFXFKVGLB-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H38FN7.2C27H34N6O2.C22H27F3N4O.C22H30N6.C21H29N5O/c1-22(2)29-35-27(18-39(29)31-19-30(20-31,21-31)37-14-12-36(11-8-32)13-15-37)24-16-28-26(34-17-24)7-10-38(28)23(3)25-6-4-5-9-33-25;2*1-18(2)25-31-22(14-33(25)27-15-26(16-27,17-27)32-8-10-34-11-9-32)20-12-23(24(28)30-13-20)35-19(3)21-6-4-5-7-29-21;1-14(2)29-19(20-11-21(12-20,13-20)28-4-6-30-7-5-28)9-18(27-29)16-8-17(22(23,24)25)15(3)26-10-16;1-15-9-17(10-24-19(15)23)18-11-28(20(25-18)16-3-4-16)22-12-21(13-22,14-22)27-7-5-26(2)6-8-27;1-14(2)26-18(9-17(24-26)16-8-15(3)19(22)23-10-16)20-11-21(12-20,13-20)25-4-6-27-7-5-25/h4-7,9-10,16-18,22-23H,8,11-15,19-21H2,1-3H3;2*4-7,12-14,18-19H,8-11,15-17H2,1-3H3,(H2,28,30);8-10,14H,4-7,11-13H2,1-3H3;9-11,16H,3-8,12-14H2,1-2H3,(H2,23,24);8-10,14H,4-7,11-13H2,1-3H3,(H2,22,23).
What are the key properties of 5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;6-[1-[3-[4-(2-fluoroethyl)piperazin-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridine;3-methyl-5-[5-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-1-propan-2-ylpyrazol-3-yl]pyridin-2-amine;4-[3-[3-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylpyrazol-5-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-3-(1-pyridin-2-ylethoxy)pyridin-2-amine)?
5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;6-[1-[3-[4-(2-fluoroethyl)piperazin-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridine;3-methyl-5-[5-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-1-propan-2-ylpyrazol-3-yl]pyridin-2-amine;4-[3-[3-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylpyrazol-5-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-3-(1-pyridin-2-ylethoxy)pyridin-2-amine) has a molecular weight of 2643.41 g/mol, XLogP of 23.42, 34 rotatable bonds, 4 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;6-[1-[3-[4-(2-fluoroethyl)piperazin-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]-1-(1-pyridin-2-ylethyl)pyrrolo[3,2-b]pyridine;3-methyl-5-[5-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-1-propan-2-ylpyrazol-3-yl]pyridin-2-amine;4-[3-[3-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylpyrazol-5-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-3-(1-pyridin-2-ylethoxy)pyridin-2-amine) is sourced from PubChem (CID 158232348), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).